Boston Scientific Corp <BSX.N>: Citigroup cuts to neutral from buy; cuts target price to $50 from $57
BSX•Related News
Enova International, Inc. <ENVA.N>: Stephens cuts target price to $205 from $275
ENVA•
Red Violet Inc <RDVT.O>: Raymond James initiates coverage with outperform rating; target price $90
RDVT•
Heartland Express declares regular quarterly cash dividend of $0.02 per share
HTLD•
Realty Income Corporation <O.N>: Mizuho cuts target price to $61 from $66
O•
Aethlon Medical agrees all-stock merger with North Immunology
AEMD•